Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects With Ocular Redness.
| Status: | Completed |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/5/2014 |
| Start Date: | November 2013 |
| End Date: | January 2014 |
| Contact: | Kris Hartman |
| Email: | kris.hartman@bausch.com |
| Phone: | 585-338-5165 |
Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Used Four Times Daily in a Population of Adult and Geriatric Subjects With Ocular Redness
To compare the efficacy and safety of brimonidine tartrate ophthalmic solution 0.025% with
its vehicle for treating ocular redness in a population of adult and geriatric participants
with ocular redness.
its vehicle for treating ocular redness in a population of adult and geriatric participants
with ocular redness.
Inclusion Criteria:
- At least 18 years of age.
- Have a history of redness relief drops use, or expressed a desire to use drops for
redness relief, within the last 6 months.
- Have ocular health within normal limits including a calculated best-corrected visual
acuity of 0.3 logMAR or better in each eye, as measured using an ETDRS chart.
Exclusion Criteria:
- Any ocular/systemic health problems.
- Use of any disallowed medications.
We found this trial at
1
site
Click here to add this to my saved trials
